Excelsior Medical Co (TPE:4104) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4104 Excelsior Medical Co Ltd TPE:4104
87 GF Score
Price NT$70.00
GF Value NT$87.68
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Excelsior Medical Co FFO per Share?

FFO per Share only applies to REITs.

TPE:4104
87GF Score
Excelsior Medical Co Ltd TPE:4104
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?

Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued. The current stock price of NT$70.00 is trading 20.2% below its estimated GF Value™ of NT$87.68. GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.

Key valuation signals for TPE:4104:

  • FFO per Share:
  • GF Value™: NT$87.68 vs. price of NT$70.00 (20.2% below fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Excelsior Medical Co Business Description

Address Zhongzheng Road, No. 880, 17th Floor, Zhonghe District, New Taipei City, TWN, 235
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
87GF Score

Get the complete analysis for TPE:4104

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$70.00
Price
NT$87.68
GF Value